association

Full identifier: http://purl.org/np/RAUwb987Ez69btjLzqpQ0oRRxZ2zo4NIHG_lXiK8Pi6fE#association

Assigned to 1 class:

Minted in Nanopublication

 RAUwb987Ez comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RAUwb987Ez... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-07-03T12:07:24.170+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RAUwb987Ez... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAManV5GZI... RAManV5GZI .
This is the identifier for this whole nanopublication. http://purl.org/np/RAUwb987Ez... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RAUwb987Ez... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T10:07:24.170Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
nizatidineoral solution is indicated for up to 8 weeks for the treatment of active duodenal ulcer in most patients the ulcer will heal within 4 weeks nizatidineoral solution is indicated for maintenance therapy for duodenal ulcer patients at a reduced dosage of 15 mg h s after healing of an active duodenal ulcer the consequences of continuous therapy with nizatidine for longer than 1 year are not known nizatidine oral solution is indicated for up to 12 weeks for the treatment of endoscopically diagnosed esophagitis including erosive and ulcerative esophagitis and associated heartburn due to gerd nizatidine oral solution is indicated for up to 8 weeks for the treatment of active benign gastric ulcer before initiating therapy care should be taken to exclude the possibility of malignant gastric ulceration in pediatric patients nizatidine oral solution is indicated for ages 12 years and older nizatidine oral solution is indicated for up to 8 weeks for the treatment of endoscopically diagnosed esophagitis including erosive and ulcerative esophagitis and associated heartburn due to gerd
Leoni Bücken
2021-07-03T10:07:24.170Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T10:07:24.170Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T10:07:24.170Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T10:07:24.170Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T10:07:24.170Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T10:07:24.170Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-07-03T10:07:24.170Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)